文献

J-GLOBAL ID：201802277961175473   整理番号：18A1922303

日本におけるヒトT細胞白血病ウイルス1型定量PCRのための指定値を持つ標準物質の開発

Development of reference material with assigned value for human T-cell leukemia virus type 1 quantitative PCR in Japan

著者 (32件)： Kuramitsu Madoka (Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan) ,  Okuma Kazu (Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan) ,  Nakashima Makoto (Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan) ,  Sato Tomoo (Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki, Japan) ,  Sasaki Daisuke (Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan) ,  Hasegawa Hiroo (Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan) ,  Umeki Kazumi (Department of Rheumatology, Infectious Diseases and Laboratory Medicine, University of Miyazaki, Miyazaki, Japan) ,  Kubota Ryuji (Division of Molecular Pathology, Center for Chronic Viral Diseases, Kagoshima University, Kagoshima, Japan) ,  Sasada Keiko (Department of Laboratory Medicine, Kumamoto University Hospital, Kumamoto, Japan) ,  Sobata Rieko (Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan) ,  Matsumoto Chieko (Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan) ,  Kaneko Noriaki (Department of Infection and Immunology, SRL Inc., Tokyo, Japan) ,  Tezuka Kenta (Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan) ,  Matsuoka Sahoko (Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan) ,  Utsunomiya Atae (Department of Hematology, Imamura General Hospital, Kagoshima, Japan) ,  Koh Ki-Ryang (Department of Hematology, Osaka General Hospital of West Japan Railway Company, Osaka, Japan) ,  Ogata Masao (Department of Hematology, Oita University Hospital, Oita, Japan) ,  Ishitsuka Kenji (Division of Hematology and Immunology, Center for Chronic Viral Diseases, Kagoshima University, Kagoshima, Japan) ,  Taki Mai (Rakuwakai Kyoto Medical Examination Center, Kyoto, Japan) ,  Nosaka Kisato (Department of Hematology, Kumamoto University of Medicine, Kumamoto, Japan) ,  Uchimaru Kaoru (Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan) ,  Uchimaru Kaoru (Department of Hematology and Oncology, Research Hospital, Institute of Medical Science, The University of Tokyo, Tokyo, Japan) ,  Iwanaga Masako (Department of Frontier Life Science, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan) ,  Sagara Yasuko (Japanese Red Cross Kyushu Block Blood Center, Fukuoka, Japan) ,  Yamano Yoshihisa (Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki, Japan) ,  Okayama Akihiko (Department of Rheumatology, Infectious Diseases and Laboratory Medicine, University of Miyazaki, Miyazaki, Japan) ,  Miura Kiyonori (Department of Obstetrics and Gynecology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan) ,  Satake Masahiro (Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan) ,  Saito Shigeru (Department of Obstetrics and Gynecology, University of Toyama, Toyama, Japan) ,  Watanabe Toshiki (Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan) ,  Watanabe Toshiki (Department of Advanced Medical Innovation, Graduate School of Medicine, St. Marianna University, Kawasaki, Japan) ,  Hamaguchi Isao (Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan)
資料名： Microbiology and Immunology  (Microbiology and Immunology)
巻： 62  号： 10  ページ： 673-676  発行年： 2018年10月 
JST資料番号： W1957A  ISSN： 0385-5600  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： オーストラリア (AUS)  言語： 英語 (EN)

抄録/ポイント： ヒトT細胞白血病ウイルス1型(HTLV-1)プロウイルスの定...

シソーラス用語： プロウイルス ,...
準シソーラス用語： *HTLV1 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1922303&from=J-GLOBAL&jstjournalNo=W1957A") }}

著者キーワード (4件)： ヒトT細胞白血病ウイルス1型 ,  プロウイルス負荷 ,  定量的PCR ,  標準

分類 (2件)： 微生物検査法  (EG02020G) ,  遺伝学研究法  (EC01020N)

タイトルに関連する用語 (6件)： 日本 ,  ヒトT細胞白血病ウイルス1型 ,  定量PCR ,  指定値 ,  標準物質 ,  開発